Mitra Ramgopal
Stock Analyst
(n/a)
# 2,276
Out of 4,648 analysts
21
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Mitra Ramgopal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCPC Balchem | Upgrades: Buy | $175 | $171.05 | +2.31% | 6 | Feb 22, 2022 | |
| TRNS Transcat | Upgrades: Buy | $60 | $99.07 | -39.44% | 2 | May 19, 2021 | |
| AMN AMN Healthcare Services | Maintains: Buy | $72 → $70 | $38.12 | +83.65% | 5 | Jun 16, 2020 | |
| ADUS Addus HomeCare | Maintains: Buy | $96 → $115 | $128.08 | -10.21% | 4 | Jun 1, 2020 | |
| USPH U.S. Physical Therapy | Maintains: Buy | $128 → $80 | $83.00 | -3.61% | 1 | Mar 27, 2020 | |
| BEAT HeartBeam | Maintains: Buy | $81 → $75 | $2.45 | +2,963.22% | 3 | Feb 27, 2020 |
Balchem
Feb 22, 2022
Upgrades: Buy
Price Target: $175
Current: $171.05
Upside: +2.31%
Transcat
May 19, 2021
Upgrades: Buy
Price Target: $60
Current: $99.07
Upside: -39.44%
AMN Healthcare Services
Jun 16, 2020
Maintains: Buy
Price Target: $72 → $70
Current: $38.12
Upside: +83.65%
Addus HomeCare
Jun 1, 2020
Maintains: Buy
Price Target: $96 → $115
Current: $128.08
Upside: -10.21%
U.S. Physical Therapy
Mar 27, 2020
Maintains: Buy
Price Target: $128 → $80
Current: $83.00
Upside: -3.61%
HeartBeam
Feb 27, 2020
Maintains: Buy
Price Target: $81 → $75
Current: $2.45
Upside: +2,963.22%